Ayloo Subhashini, Armstrong John, Hurton Scott, Molinari Michele
Subhashini Ayloo, John Armstrong, Scott Hurton, Michele Molinari, Department of Surgery, Dalhousie University, Halifax, Nova Scotia B3H 2Y9, Canada.
World J Transplant. 2015 Sep 24;5(3):95-101. doi: 10.5500/wjt.v5.i3.95.
The percentage of overweight and obese patients (OPs) waiting for a liver transplant continues to increase. Despite the significant advances occurred in bariatric medicine, obesity is still considered a relative contraindication to liver transplantation (LT). The main aim of this review is to appraise the literature on the outcomes of OPs undergoing LT, treatments that might reduce their weight before, during or after surgery, and discuss some of the controversies and limitations of the current knowledge with the intent of highlighting areas where future research is needed.
等待肝移植的超重和肥胖患者的比例持续上升。尽管减肥医学取得了重大进展,但肥胖仍被视为肝移植(LT)的相对禁忌证。本综述的主要目的是评估有关肥胖患者肝移植结局的文献、手术前、手术期间或手术后可能减轻其体重的治疗方法,并讨论当前知识的一些争议和局限性,以突出未来需要研究的领域。